1,370 results on '"Stefan, Norbert"'
Search Results
2. Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial
3. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial
4. Diabetes und Fettleber
5. Obesity and Type 2 Diabetes
6. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
7. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
8. Automated shape-independent assessment of the spatial distribution of proton density fat fraction in vertebral bone marrow
9. Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
10. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
11. Diabetes und Fettleber
12. Precision subclassification of type 2 diabetes: a systematic review
13. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)
14. Prädiabetes – eine Krankheit?
15. A global research priority agenda to advance public health responses to fatty liver disease
16. Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment
17. Glucagon und Katecholamine – Gegenspieler des Insulins
18. Insulin – das wichtigste anabole Hormon
19. The role of hepatokines in NAFLD
20. Diabetes und Fettleber
21. A global view of the interplay between non-alcoholic fatty liver disease and diabetes
22. Diabetes und Metabolische Dysfunktion-assoziierte Steatotische Lebererkrankung.
23. Fetuin-A and risk of diabetes-related vascular complications: a prospective study
24. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance
25. SARS-CoV-2 fires up inflammation in adipose tissue
26. Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
27. Liver-targeting drugs and their effect on blood glucose and hepatic lipids
28. 11 Nichtalkoholische Lebererkrankungen
29. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells
30. Diabetes und Fettleber
31. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
32. Causes, consequences, and treatment of metabolically unhealthy fat distribution
33. Comparison of the accuracy of commercial two-point and multi-echo Dixon MRI for quantification of fat in liver, paravertebral muscles, and vertebral bone marrow
34. Diabetes and Fatty Liver
35. Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
36. Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
37. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci
38. Fettleber und Diabetes: Pathomechanismen
39. Neue arzneitherapeutische Optionen bei nichtalkoholischer Fettlebererkrankung
40. Diabetes und Fettleber
41. Elevated circulating follistatin associates with an increased risk of type 2 diabetes
42. Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation
43. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
44. Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study
45. Metabolic disorders, COVID-19 and vaccine-breakthrough infections
46. Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
47. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort
48. SGLT2 inhibition in addition to lifestyle intervention and risk for complications in subtypes of patients with prediabetes - a randomized, placebo controlled, multi-center trial (LIFETIME) – rationale, methodology and design
49. Diabetes und Fettleber
50. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.